Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% within the next six months [5]. Core Insights - The company achieved a revenue of 9.178 billion yuan in 2025, representing a year-on-year growth of 35.12%, with a net profit attributable to shareholders of 1.103 billion yuan, up 41.14% year-on-year [1]. - The company's main brand, Han Shu, continues to show strong growth, contributing 7.36 billion yuan in revenue, a 31.6% increase year-on-year, and accounting for 80.2% of total revenue [1]. - The online sales channel has seen rapid growth, with revenue reaching 8.618 billion yuan, a 40.1% increase year-on-year, while offline sales have declined by 14.3% [2]. - The gross profit margin for 2025 was 76.43%, an increase of 1.21 percentage points year-on-year, indicating stable profitability [3]. Financial Summary - The company forecasts revenues of 11.438 billion yuan, 13.795 billion yuan, and 16.274 billion yuan for 2026, 2027, and 2028, respectively, with net profits projected at 1.391 billion yuan, 1.699 billion yuan, and 2.063 billion yuan [4]. - The earnings per share (EPS) are expected to rise from 2.77 yuan in 2026 to 5.18 yuan in 2028, reflecting a strong growth trajectory [4]. - The price-to-earnings (P/E) ratio is projected to decrease from 14.23 in 2026 to 9.60 in 2028, suggesting an attractive valuation as earnings grow [4].

Investment Rating - The report maintains an "Overweight" rating for the retail sector, emphasizing investment opportunities in both high and low-end consumer segments [1]. Core Insights - The retail sector is currently experiencing low valuations across multiple sub-sectors, providing a favorable environment for medium to long-term investments. As of March 20, 2026, several core companies in segments such as gold and jewelry, travel chains, education services, and retail have seen their valuations drop to below the historical 10th percentile, indicating high investment value [5][10]. - The retail sector is characterized by companies with light asset operations and low capital expenditure needs, resulting in strong cash flows and high dividend payouts. As of March 20, 2026, leading companies in sectors like gold and jewelry, education, retail, and dining have dividend yields ranging from 5% to nearly 10%, making them attractive for investors [5][10]. Summary by Sections Investment Opportunities - The report highlights a selection of 10 companies that exhibit both low valuations and high dividend yields, including: 1. Shangmei Co., Ltd. (2145.HK): PE of 15.3x, dividend yield of 5.0% 2. China Oriental Education (0667.HK): PE of 11.4x, dividend yield of 7.6% 3. Action Education (605098.SH): dividend payout ratio near 100%, yield of 5.6% 4. Beijing Renli (600861.SH): PE of 8.9x, yield of 5.6% 5. Xiaomen Xiangyu (600057.SH): PE of 9.2x, yield of 5.3% 6. Zhou Dasheng (002867.SZ): yield of 9.8%, PE of 10.4x 7. Liufu Group (0590.HK): yield of 8.6%, PE of 8.6x 8. Chow Tai Fook (1929.HK): yield of 7.9%, payout ratio over 90% 9. Haidilao (6862.HK): yield of 5.9%, improving turnover rate [5][10]. Market Performance Review - From March 16 to March 20, 2026, the Shenwan Retail Index decreased by 4.55%, while the Shanghai Composite Index fell by 3.38%. Year-to-date, the Shenwan Retail Index has declined by 12.57% [5][10].

Investment Rating - The report maintains an "Overweight" rating for the retail sector, emphasizing investment opportunities in both high-end and low-end consumer segments [1]. Core Insights - The retail sector is currently experiencing a weak overall sentiment, but many sub-sectors are at historically low valuation levels, providing a good safety margin for medium to long-term investments. Key segments such as gold and jewelry, travel chains, education services, and retail are noted to have core companies that have fallen below the historical 10th percentile in terms of PE-TTM ratios, indicating high investment value [5][10]. - The retail sector is characterized by companies with light asset operations and low capital expenditure needs, resulting in strong cash flows and high dividend payouts. As of March 20, 2026, several leading companies in the sector have attractive dividend yields, with some reaching as high as 10% [5][10]. - A selection of 10 recommended stocks with low valuations and high dividend yields has been identified, including companies like Shangmei Co. (PE 15.3, dividend yield 5.0%), China Oriental Education (PE 11.4, dividend yield 7.6%), and others, showcasing the potential for defensive investment strategies [5][10]. Summary by Sections Industry Trends - The report highlights that multiple sub-sectors within the retail industry are currently undervalued, with many companies showing a PE-TTM ratio below the historical 10th percentile, indicating a favorable entry point for investors [5][10]. Dividend Observations - The retail sector's companies generally maintain high dividend payout ratios due to their stable business models and strong cash flows. As of March 20, 2026, several leading firms exhibit dividend yields of 5% to nearly 10%, making them attractive for income-focused investors [5][10]. Recommended Stocks - The report lists 10 stocks that combine low valuation with high dividend characteristics, including: 1. Shangmei Co. (2145.HK): PE 15.3, dividend yield 5.0% 2. China Oriental Education (0667.HK): PE 11.4, dividend yield 7.6% 3. Action Education (605098.SH): dividend payout ratio near 100%, yield 5.6% 4. Beijing Renli (600861.SH): PE 8.9, yield 5.6% 5. Xiaomen Xiangyu (600057.SH): PE 9.2, yield 5.3% 6. Zhou Daxing (002867.SZ): yield 9.8% 7. Liufu Group (0590.HK): yield 8.6% 8. Zhou Dafu (1929.HK): yield 7.9% 9. Haidilao (6862.HK): yield 5.9% [5][10].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company is expected to achieve a revenue of 9.0 to 9.1 billion yuan in 2025, representing a year-on-year growth of 34.0% to 35.4%. The net profit is projected to be between 1.14 billion and 1.16 billion yuan, reflecting a year-on-year increase of 41.9% to 44.4% [7] - The main brand, Han Shu, continues to lead the market, supported by successful product lines and expansion into high-growth categories such as men's skincare and hair care [7] - The company is effectively leveraging its multi-brand strategy, with sub-brands like Newpage showing significant growth potential, contributing to a second growth curve [7] Financial Projections - Total revenue projections for the company are as follows: - 2023: 4,191 million yuan - 2024: 6,793 million yuan (62.08% YoY growth) - 2025: 9,094 million yuan (33.88% YoY growth) - 2026: 11,167 million yuan (22.80% YoY growth) - 2027: 13,492 million yuan (20.82% YoY growth) [1] - Net profit projections are as follows: - 2023: 461.10 million yuan - 2024: 781.21 million yuan (69.42% YoY growth) - 2025: 1,110.51 million yuan (42.15% YoY growth) - 2026: 1,402.34 million yuan (26.28% YoY growth) - 2027: 1,752.63 million yuan (24.98% YoY growth) [1] - The latest diluted EPS estimates are: - 2023: 1.16 yuan - 2024: 1.96 yuan - 2025: 2.79 yuan - 2026: 3.52 yuan - 2027: 4.40 yuan [1] Market Data - The closing price of the stock is 57.60 HKD, with a market capitalization of approximately 10,469.21 million HKD [5] - The price-to-earnings (P/E) ratios for the years 2025 to 2027 are projected to be 18.17, 14.39, and 11.51 respectively [1]

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, highlighting potential growth despite recent market underperformance [2][3]. Core Insights - The cosmetics and medical beauty sector has underperformed the market, with the Shenwan Beauty Care Index declining by 3.0% from February 27 to March 6, 2026. The Shenwan Cosmetics Index fell by 4.9%, while the Shenwan Personal Care Products Index decreased by 0.7% [3][4]. - Upbeauty Co., Ltd. has exceeded expectations for 2025, forecasting revenue between 9.1 billion and 9.2 billion yuan, representing a year-on-year increase of 34.0%-35.4%. The net profit attributable to shareholders is expected to be between 1.14 billion and 1.16 billion yuan, reflecting a growth of 41.9%-44.4% [9]. - The report emphasizes the importance of Upbeauty’s core anti-aging product line, which is continuously iterating to meet the upgrading trend of domestic anti-aging consumption, thereby enhancing both brand and product strength [9]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the overall market, with significant declines in key indices [3][4]. - The report notes that the Shenwan Cosmetics Index's decline of 4.9% is notably worse than the Shenwan A Index by 2.5 percentage points [4]. Company Highlights - Upbeauty Co., Ltd. is highlighted for its strong performance, with a positive earnings forecast for 2025, driven by its core business and product innovation [9]. - Huaxi Biological (688363.SH) reported a net profit of 291 million yuan for 2025, a year-on-year increase of 67.03%, indicating a successful strategic transformation [3][9]. - Yixian E-commerce reported a revenue of 4.3 billion yuan for 2025, a 26.7% increase year-on-year, marking its first annual Non-GAAP profit since its listing [22]. Market Trends - The report identifies a structural growth phase in the nutrition and health food market, with a market size reaching over 100 billion yuan, significantly outpacing traditional food sectors [11]. - The online DTC channel is recognized as a core growth engine for the industry, with companies like Xizi Health achieving over 98% of their revenue from online sales [11]. Investment Recommendations - The report recommends focusing on companies with strong channel and brand matrices, such as Upbeauty Co., Ltd. and Mao Ge Ping, which are expected to see high GMV growth [3][9]. - It also suggests monitoring companies with improving performance metrics, including Proya, Marubi, and Huaxi Biological, as well as those in the maternal and infant sector like Shengbeila and Kidswant [3].

Core Viewpoint - The recent controversy surrounding the ingredient EGF in the core brand Han Shu of Shangmei Co. has led to significant stock price fluctuations and raised concerns about the company's future growth plans [4][5][8]. Group 1: Company Developments - Chairman Lv Yixiong announced that executive director Luo Yan purchased 364,000 shares at approximately HKD 75.5 each, totaling about HKD 66.32 million, indicating strong confidence in the company's future [2]. - The company aims to achieve a revenue target of 30 billion yuan by 2030, requiring a doubling of current revenue within five years [12][38]. - In the first half of the year, the company's revenue reached 4.1 billion yuan, with a goal of hitting 10 billion yuan in annual revenue for the new brand Newpage [11][22]. Group 2: Controversy and Market Reaction - The controversy originated from the detection of EGF in two Han Shu face masks, leading to a significant drop in stock price, with a loss of over 10 billion yuan in market value [5][8]. - Han Shu's official response included presenting third-party testing results to refute the claims, but investor concerns persisted, resulting in a 30% drop in stock price on the first trading day after the holiday [8][39]. - The Chinese Fragrance and Cosmetic Industry Association noted that there is currently no commercial ELISA kit available for testing EGF in cosmetics, which complicates the situation [9]. Group 3: Strategic Expansion Plans - The company is in a critical expansion phase, planning to launch 20 new brands between 2025 and 2027, primarily leveraging the Douyin platform for marketing [10][22]. - The company is also focusing on international markets, with a significant investment of 300 million yuan in a factory in Southeast Asia [24]. - The strategy includes hiring top talent and implementing a rigorous selection process to enhance brand development and marketing effectiveness [29][32].

Core Viewpoint - Guojin Securities has initiated coverage on Shumei Co., Ltd. (02145), recognizing it as a leading player in China's beauty and personal care industry, with a multi-brand matrix across skincare, baby care, and hair care sectors. The company primarily utilizes online channels and is expected to achieve strong growth, particularly with its main brand, Han Shu, and new brand development, leading to a target price of HKD 109.78 based on a 2025 PE of 30 times, with a "Buy" rating assigned [1]. Group 1: Company Development and Strategy - The company's multi-brand expansion strategy shares similarities with Anta Sports, focusing on market-driven approaches, precise brand positioning, and effective marketing to quickly address consumer pain points [2]. - The trend of refined channel operations is evident as the company restructures its channel strategy around Douyin, leveraging innovative marketing and increasing self-broadcasting to achieve significant revenue and profit growth [2]. - The company ensures a steady supply of core management talent through a dual approach of internal training and external recruitment, which supports differentiated development across its brands [2]. Group 2: Growth Projections and Market Position - The company is expected to achieve substantial growth in its three main segments: skincare, baby care, and hair care, with Han Shu projected to exceed CNY 10 billion in revenue within three years [3]. - In the skincare segment, Han Shu has seen a significant market share increase through Douyin, with projected revenue growth of over 80% in 2024, despite a slowdown in H1 2025 due to channel adjustments [3]. - The baby care brand, Yiye, is experiencing rapid growth with a unique "medical research co-creation" model, expected to achieve a compound annual growth rate of over 50% in the next three years [3]. - The hair care segment is anticipated to produce major brands, with a focus on clear positioning and consumer mindset development, as well as entering faster-growing segments like anti-hair loss [3]. Group 3: Financial Forecasts - The company achieved an online sales ratio of nearly 93% in H1 2025, with Han Shu's rapid growth through Douyin contributing to projected revenues of CNY 5.591 billion in 2024, reflecting an 80.9% year-on-year increase [4]. - New brands like Yiye are also rapidly gaining traction, with projected growth rates of 498% for 2023 and 146% for H1 2025 [4]. - Earnings per share (EPS) forecasts for 2025-2027 are estimated at CNY 2.68, CNY 3.33, and CNY 4.09, respectively, with a valuation of 24 times for 2026 [4].

Core Viewpoint - Guojin Securities has initiated coverage on Shangmei Co., Ltd. (02145), recognizing it as a leading player in China's beauty and personal care industry, with a multi-brand matrix across skincare, baby care, and hair care sectors. The company is primarily focused on online channels, and given the strong growth potential of its multi-brand strategy, it has set a target price of HKD 109.78 based on a 30x PE valuation for 2025, rating it as "Buy" [1]. Group 1: Company Development and Strategy - The company's multi-brand expansion strategy shares similarities with Anta Sports, focusing on market-driven approaches that quickly identify consumer pain points and launch targeted products while leveraging impactful marketing and top-tier IP collaborations [1]. - The trend of refined channel operations is evident as the company restructures its channel strategy around Douyin, enhancing revenue and profit growth through innovative marketing and increased self-broadcasting [1]. - The company ensures a steady supply of core management talent through a dual approach of internal training and external recruitment, which supports differentiated development across its brands [1]. Group 2: Growth Projections - The company is expected to achieve significant growth in its three main segments: skincare, baby care, and hair care, with projections indicating that Han Shu could surpass CNY 10 billion in revenue within three years [2]. - In the skincare segment, Han Shu has seen a notable increase in market share through Douyin, with projected revenue growth exceeding 80% in 2024. Despite a slowdown in H1 2025 due to channel adjustments, Q3 2025 GMV is expected to grow by 50% year-on-year [2]. - The baby care brand, Yiye, is experiencing rapid growth with a projected compound annual growth rate (CAGR) exceeding 50% over the next three years, while the hair care segment is anticipated to produce major brands by leveraging clear positioning and consumer engagement strategies [2]. Group 3: Financial Forecasts - The company is projected to achieve a revenue of CNY 5.591 billion in 2024, reflecting an 80.9% year-on-year increase, with H1 2025 revenue expected to grow by 14.3% to CNY 3.344 billion [3]. - New brands like Yiye are rapidly gaining traction, with annual growth rates of 498% in 2023 and 146% in 2024, and a continued strong performance expected in H1 2025 [3]. - Earnings per share (EPS) forecasts for 2025-2027 are estimated at CNY 2.68, CNY 3.33, and CNY 4.09, respectively, with a valuation of 24x for 2026 [3].

Investment Rating - The report gives a "Buy" rating for the cosmetics and medical beauty industry, highlighting potential growth opportunities in the sector [4][13]. Core Insights - The cosmetics and medical beauty sector is currently underperforming compared to the market, with the Shenwan Beauty Care Index rising by only 0.5% from November 21 to November 28, 2025, which is lower than the overall market performance [5][4]. - The sixth China Cosmetics Annual Conference emphasized the importance of multi-brand globalization and AI empowerment for future development, with industry leaders discussing strategies for growth and market adaptation [10][4]. - The report anticipates that domestic brands will thrive during the industry's consolidation phase, leveraging innovation and consumer demand to drive growth [11][4]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weak performance, with the Shenwan Cosmetics Index increasing by 1.4%, which is 1.6 percentage points lower than the Shenwan A Index [5][4]. - Key stocks in the sector include Yanjiang Co. (+22.0%), Mingchen Health (+17.9%), and Lihe Technology (+9.9%) [6][4]. Market Trends - The report identifies trends such as the need for brands to localize when expanding internationally, the role of AI in upgrading the industry, and the focus on men's skincare and body care segments [10][4]. - The medical beauty market is expected to see growth driven by new products and consumer demand, despite some economic pressures [12][4]. Company Analysis - Qingmu Technology is highlighted as a leading player in the full-service e-commerce operation sector, with a strong focus on data and technology to drive growth [16][4]. - The report notes that the company has shown significant revenue growth, with projected revenues of 15.1 billion, 19.0 billion, and 23.4 billion yuan for 2025-2027, respectively [19][4]. Investment Recommendations - Recommended stocks include brands with strong channel and brand matrices such as Maogeping, Shuangmei, and Proya, as well as companies in the medical beauty sector like Aimeike [13][4]. - The report suggests focusing on companies with strong R&D capabilities and a broad product pipeline, particularly in the medical beauty segment [13][4].

Core Insights - Southbound funds increased their holdings in Shangmei Co., Ltd. by 198,700 shares on November 4, 2025, marking a 0.46% increase in total shares held [1][2] - Over the past five trading days, there have been four days of net increases in holdings, totaling 1,330,800 shares [1][2] - In the last twenty trading days, there were ten days of net increases, amounting to 1,400,500 shares [1][2] - As of now, southbound funds hold 43,388,700 shares of Shangmei Co., Ltd., which represents 21.02% of the company's total issued ordinary shares [1][2] Company Overview - Shangmei Co., Ltd. is primarily engaged in the production and sale of cosmetics in China [2] - The company markets brands such as "Han Shu," "Yi Ye Zi," and "Red Elephant," focusing on skincare and maternal and infant care products [2] - Products are sold through both online and offline channels, with a primary focus on the domestic market [2]